Actualizat: în urmă cu 3 ore 35 de minute
Globally, as of 9 August, 19 cases of polio due to wild poliovirus type 1 (WPV1) and 223 cases due to circulating vaccine derived poliovirus (cVDPV) have been reported this year. In 2022, the cVDPV cases have been reported in 15 countries, with 93% of the cases attributed to cVDPV type 2 (cVDPV2).
According to a group of Chinese scientists, the detection of a previously unknown, phylogenetically distinct henipavirus, named Langya henipavirus (LayV), was reported in China.
World Hepatitis Day is marked on 28 July each year to increase the awareness and understanding of viral hepatitis.
ECDC to participate in a pilot project for the European Health Data Space: towards new opportunities for health research in Europe
The European Commission recently announced its decision to choose a consortium led by the French Health Data Hub to set up a pilot project for the European Health Data Space (EHDS). This project will aim to feed the legislative discussions around the draft regulation proposed by the European Commission on May 3rd on the European Health Data Space.
ECDC releases publications on COVID-19 vaccination strategies and joint ECDC-WHO report on considerations for respiratory diseases as guidance for the second half of the year
Following the joint statement from the European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) on 11 July 2022, ECDC has released Preliminary public health considerations for COVID-19 vaccination strategies in the second half of 2022. ECDC, in collaboration with the World Health Organization (WHO) Regional Office for Europe, has also published Operational considerations for respiratory virus surveillance in Europe.
As of 15 July 2022, 401 confirmed (n=399) and probable (n=2) cases of monophasic S. Typhimurium have been identified in the EU/EEA and the United Kingdom.
ECDC Director statement on the Commission proposal for a new legislation on blood, tissues, and cells
The ECDC Director has issued a statement in light of the Commission’s proposal for a new legislation on blood, tissues, and cells.
The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) are recommending that second booster doses of COVID-19 vaccines be considered for people between 60 and 79 years old and people with medical conditions putting them at high risk of severe disease.
The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) have updated public health recommendations on the use of additional booster doses of COVID-19 vaccines this summer and in the upcoming autumn and winter seasons.
The European Centre of Disease Prevention and Control has today released the Rapid Risk Assessment Monkeypox multi-country outbreak - first update. Since early May 2022 and as of 7 July, cases of monkeypox have been reported in twenty-six European Union/European Economic Area (EU/EEA) countries.
A peek behind the scenes at the European Centre for Disease Prevention and Control - the EU agency that aims to identify, assess and communicate current and emerging threats to human health posed by infectious diseases in Europe.
ECDC and WHO produce risk communication and community engagement advice, toolkit for public health authorities and event organisers
ECDC and WHO have worked together to publish a series of examples of risk communication and community engagement (RCCE) strategies for public health authorities in the context of the ongoing monkeypox outbreak, building on previous RCCE advice.
This weekly report provides an overview of the epidemiological situation of the COVID-19 pandemic and COVID-19 vaccine rollout by country.
A new e-learning course aimed at understanding and addressing online vaccination misinformation is now available in the ECDC Virtual Academy. It was designed to support public health practitioners and risk communicators in fighting the spread of vaccination misinformation on social media and other digital platforms.
Cases of monkeypox have been continuously reported across the European region since the initial reports on 16 May. Due to this ongoing transmission, and following guidance published for event organisers and people at risk, the European Centre for Disease Prevention and Control (ECDC) has today published Considerations for contact tracing during the monkeypox outbreak in Europe, 2022.
A regional and country-level overview of data reported to TESSy by countries in the WHO European Region, including the Western Balkans.
Dr Andrea Ammon (Director, ECDC) has invited all the EU Member States to state their interest in hosting the ESCAIDE conference in 2023 or 2027.
This report provides an overview of the total number of cases of monkeypox reported to ECDC and the WHO Regional Office for Europe through IHR/EWRS mechanisms .
From 6–10 June, ECDC hosted a training module on rapid risk assessment, surveillance, and survey methods for MediPIET fellows in Stockholm.
Since the start of the outbreak: A total of 1 160 cases have been confirmed in the EU/EEA and 1 884 cases have been confirmed worldwide (including the EU/EEA).